Trial intelligence / Profile preview

Aggressive versus non-aggressive lactated Ringer fluid resuscitation in early acute pancreatitis

2019-000788-26Phase 4Terminated

Sponsor
Enrique de Madaria
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of lactated ringer's solution in acute pancreatitis (AP) (2 arms), sponsored by Enrique de Madaria. Primary endpoint: Incidence of moderate-to-severe acute pancreatitis according to the revised Atlanta classification. Started Apr 2019; status: terminated.

02

Drugs

lactated ringer's solution
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on 2019-000788-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-000788-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call